Search research articles
Contact Us
Filters
Showing results (51-60 of 208) with videos related to
Page
of 21
Sort By:
Clinical Rheumatology
|
June 24, 2020
Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis
Cristina Párraga Prieto, Fowzia Ibrahim, Richard Campbell, et al.
Rheumatology (Oxford, England)
|
November 26, 2015
Cardiovascular risk with NSAIDs in rheumatoid arthritis: an analysis using routinely collected data
Antigoni Grigoriou, Fowzia Ibrahim, Khaldoun Chaabo, et al.
Rheumatology (Oxford, England)
|
March 13, 2018
Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
Imran H Yusuf, Joanna M Ledingham, Elizabeth MacPhie, et al.
Rheumatology Advances in Practice
|
August 27, 2025
Feasibility of remote measurement in intensive longitudinal data collection for rheumatoid arthritis patients commencing a new treatment
Hsiu Yen Tung, James Galloway, Faith Matcham, et al.
RMD Open
|
August 17, 2021
Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales
Magdalena Zasada, Mark Yates, Nicola Ayers, et al.
Clinical and Experimental Rheumatology
|
December 7, 2021
Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination
James Galloway, Tim Raine, Lucy Rivett, et al.
Pharmacoeconomics
|
September 27, 2025
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Xiaoyu Zhang, Jiaru Liu, Zhengwei Wang, et al.
JACC. Cardiovascular Imaging
|
April 3, 2024
Methotrexate in Cardiac Sarcoidosis: Absence of Evidence Is Not Evidence of Absence
Arthur M F Yee, Matthew C Baker, Elizabeth W Frame, et al.
Rheumatology (Oxford, England)
|
May 15, 2024
Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UK
Zixing Tian, Lianne Kearsley-Fleet, James Galloway, et al.
Journal of Clinical Medicine
|
August 12, 2023
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis
Fabiola Atzeni, Laura La Corte, Mariateresa Cirillo, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 208) with videos related to
Sort By:
Page
of 21
Clinical Rheumatology
|
June 24, 2020
Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis
Cristina Párraga Prieto, Fowzia Ibrahim, Richard Campbell, et al.
Rheumatology (Oxford, England)
|
November 26, 2015
Cardiovascular risk with NSAIDs in rheumatoid arthritis: an analysis using routinely collected data
Antigoni Grigoriou, Fowzia Ibrahim, Khaldoun Chaabo, et al.
Rheumatology (Oxford, England)
|
March 13, 2018
Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
Imran H Yusuf, Joanna M Ledingham, Elizabeth MacPhie, et al.
Rheumatology Advances in Practice
|
August 27, 2025
Feasibility of remote measurement in intensive longitudinal data collection for rheumatoid arthritis patients commencing a new treatment
Hsiu Yen Tung, James Galloway, Faith Matcham, et al.
RMD Open
|
August 17, 2021
Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales
Magdalena Zasada, Mark Yates, Nicola Ayers, et al.
Clinical and Experimental Rheumatology
|
December 7, 2021
Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination
James Galloway, Tim Raine, Lucy Rivett, et al.
Pharmacoeconomics
|
September 27, 2025
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Xiaoyu Zhang, Jiaru Liu, Zhengwei Wang, et al.
JACC. Cardiovascular Imaging
|
April 3, 2024
Methotrexate in Cardiac Sarcoidosis: Absence of Evidence Is Not Evidence of Absence
Arthur M F Yee, Matthew C Baker, Elizabeth W Frame, et al.
Rheumatology (Oxford, England)
|
May 15, 2024
Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UK
Zixing Tian, Lianne Kearsley-Fleet, James Galloway, et al.
Journal of Clinical Medicine
|
August 12, 2023
Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis
Fabiola Atzeni, Laura La Corte, Mariateresa Cirillo, et al.
Page
of 21